Principal Financial Group
CODX

Principal Financial Group’s Co-Diagnostics CODX Stock Holding History

Principal Financial Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,655
Closed -$307K – 2530
2022
Q1 		$307K Sell
1,655
-839
-34% -$174K ﹤0.01% 2234
2021
Q4 		$668K Sell
2,494
-2,180
-47% -$572K ﹤0.01% 2063
2021
Q3 		$1.36M Sell
4,674
-64
-1% -$18.7K ﹤0.01% 1938
2021
Q2 		$1.17M Sell
4,738
-673
-12% -$173K ﹤0.01% 2006
2021
Q1 		$1.55M Buy
5,411
+413
+8% +$165K ﹤0.01% 1905
2020
Q4 		$1.4M Buy
+4,998
New +$1.85M ﹤0.01% 1869

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Principal Financial Group's CODX Position: Q2 2022 in Review

Principal Financial Group sold out of Co-Diagnostics (CODX) in Q2 2022, closing a stake of 1,655 shares — an estimated $307K sold.

Principal Financial Group first reported a position in CODX in Q4 2020 and held it in 6 quarters. The position peaked at $1.55M in Q1 2021. 69 funds tracked by Wall St. Rank hold CODX as of Q2 2022.

  • Principal Financial Group reported no remaining Co-Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 1,655 Co-Diagnostics shares in Q2 2022, an estimated $307K.
  • Principal Financial Group first reported a position in Co-Diagnostics in Q4 2020 and held it in 6 quarters.
  • Principal Financial Group's Co-Diagnostics position peaked at $1.55M in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.